TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Tizona Therapeutics, Inc
Tizona Therapeutics, Inc
Second Life Therapeutics
Pfizer
Numab Therapeutics AG
Ikena Oncology
Ikena Oncology
Multitude Therapeutics Inc.
Novartis
MacroGenics
SpeciCare
Bayer